Ihr Broker

  • DAX 0,70
  • EUR/USD 0,50
  • GOLD 0,30

Nur Spreads

Keine Kommission

Jetzt registrieren

CFDs sind komplexe Instrumente und umfassen aufgrund der Hebelfinanzierung ein hohes Risiko, schnell Geld zu verlieren.

4basebio AG, DE000A2YN801

4basebio AG, DE000A2YN801

14.02.2020 - 15:02:23

4basebio AG: 4basebio AG announces results of the public share buyback offerand final purchase price for the share buy back

Investors' information: investors.4basebio.com

MC Services AG (Investor Relations and International Media Relations) Julia Hofmann Phone: +49 89 210228 0 Email: 4basebio@mc-services.eu ### This publication is intended for information only and constitutes neither an offer to sell nor an invitation to buy securities. Some statements included in this press release, relating neither to proven financial results nor other historical data, should be viewed as forward-looking, i.e. not definite. Such statements are mainly predictions of future results, trends, plans or goals. These statements should not be considered to be total guarantees since given their very nature they are subject to known and unknown risks and imponderability and can be affected by other factors as a consequence of which the actual results, plans and goals of 4basebio AG may deviate greatly from the established conclusions or implied predictions contained in such statements. 4basebio does not undertake to publicly update or revise these statements in the light of new information or future results or for any other reason. ###

 

Additional features:Document: http://n.eqs.com/c/fncls.ssp?u=MRVHYJGDPMDocument title: Volum_Eng

14.02.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

Language: English Company: 4basebio AG Waldhofer Str. 102 69123 Heidelberg

Germany Phone: +49 (0) 6221 3540 125 Fax: +49 (0) 6221 3540 127 E-mail: 4basebio@expedeon.com Internet: www.4basebio.com ISIN: DE000A2YN801 WKN: A2YN80 Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange EQS News ID: 975851   End of News DGAP News Service

975851  14.02.2020 

@ dgap.de